{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:47:37Z","timestamp":1761630457606},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,6,9]],"date-time":"2007-06-09T00:00:00Z","timestamp":1181347200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2007,9,21]]},"DOI":"10.1007\/s12016-007-0009-8","type":"journal-article","created":{"date-parts":[[2007,6,8]],"date-time":"2007-06-08T15:27:45Z","timestamp":1181316465000},"page":"131-137","source":"Crossref","is-referenced-by-count":45,"title":["Clinical Thrombotic Manifestations in SLE Patients With and Without Antiphospholipid Antibodies: A 5-year Follow-up"],"prefix":"10.1007","volume":"32","author":[{"given":"Tunde","family":"Tarr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Lakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harjit Pal","family":"Bhattoa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pal","family":"Soltesz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyula","family":"Szegedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emese","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,6,9]]},"reference":[{"key":"9_CR1","first-page":"924","volume":"27","author":"G Lakos","year":"2000","unstructured":"Lakos G, Kiss E, Regeczy N, Tarjan P, Soltesz P, Zeher M et al (2000) Anti-prothrombin and anti-annexin V antibodies imply a risk of thrombosis in patients with systemic lupus erythematosus. J Rheumatol 27:924\u2013929","journal-title":"J Rheumatol"},{"key":"9_CR2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S1568-9972(02)00084-8","volume":"1","author":"E Matsuura","year":"2002","unstructured":"Matsuura E, Kobayashi K, Koike T, Shoenfeld Y (2002) Autoantibody mediated atherosclerosis. Autoimmun Rev 1:348\u2013353","journal-title":"Autoimmun Rev"},{"key":"9_CR3","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"M Hochberg","year":"1997","unstructured":"Hochberg M (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725\u20131743","journal-title":"Arthritis Rheum"},{"key":"9_CR4","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1191\/0961203303lu339oa","volume":"12","author":"P Soltesz","year":"2003","unstructured":"Soltesz P, Veres K, Lakos G, Kiss E, Muszbek L, Szegedi G (2003) Evaluation of clinical and laboratory features of antiphospholipid syndrome: a retrospective study of 637 patients. Lupus 12:302\u2013307","journal-title":"Lupus"},{"key":"9_CR5","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","volume":"42","author":"WA Wilson","year":"1999","unstructured":"Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC et al (1999) International consensus statement on preliminary classification for definite antiphospholipid syndrome. Arthritis Rheum 42:1309\u20131311","journal-title":"Arthritis Rheum"},{"key":"9_CR6","first-page":"2531","volume":"29","author":"E Somers","year":"2002","unstructured":"Somers E, Magder LS, Petri M (2002) Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. J Rheumatol 29:2531\u20132536","journal-title":"J Rheumatol"},{"issue":"1","key":"9_CR7","first-page":"91","volume":"26","author":"M Bandt de","year":"1999","unstructured":"de Bandt M, Benali K, Guillevin L, Hachulla E, Job C, Fautrel B et al (1999) Longitudinal determination of antiphospholipid antibodies lupus patients without previous manifestations of antiphospholipid syndrome. A prospective study. J Rheumatol 26(1):91\u201396","journal-title":"J Rheumatol"},{"key":"9_CR8","first-page":"2136","volume":"126","author":"C Urfer","year":"1996","unstructured":"Urfer C, Pichler WJ, Halbling A (1996) Antiphospholipid antibodies syndrome: follow-up of patients with a high antiphospholipid antibody titer. Schweitz Med Wochenschr 126:2136\u20132140","journal-title":"Schweitz Med Wochenschr"},{"key":"9_CR9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/01.md.0000172074.53583.ea","volume":"84","author":"JA Gomez-Puerta","year":"2005","unstructured":"Gomez-Puerta JA, Martin H, Amigo MC, Aguirre MA, Camps MT, Cuadrado MJ, Hughes GR, Khamastha MA (2005) Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus? Medicine (Baltimore) 84:225\u2013230","journal-title":"Medicine (Baltimore)"},{"key":"9_CR10","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s11926-003-0023-7","volume":"5","author":"M Petri","year":"2003","unstructured":"Petri M (2003) Evidence-based management of thrombosis in the antiphospholipid antibody syndrome. Curr Rheumatol Rep 5:370\u2013373","journal-title":"Curr Rheumatol Rep"},{"key":"9_CR11","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1056\/NEJMoa035241","volume":"349","author":"MA Crowther","year":"2003","unstructured":"Crowther MA, Ginsberg JS, Julian J, Denburg J, Hirsh J, Douketis LC et al (2003) A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med 349:1133\u20131138","journal-title":"N Engl J Med"},{"key":"9_CR12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1212\/01.WNL.0000072324.59029.92","volume":"61","author":"RH Derksen","year":"2003","unstructured":"Derksen RH, De Groot PG, Kappelle LJ (2003) Low dose aspirin after ischemic stroke associated with antiphospholipid syndrome. Neurology 61:111\u2013114","journal-title":"Neurology"},{"key":"9_CR13","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1568-9972(02)00067-8","volume":"1","author":"G Ruiz-Irastorza","year":"2002","unstructured":"Ruiz-Irastorza G, Khamashta MA, Hughes GR (2002) Treatment of pregnancy loss in Hughes syndrome: a critical update. Autoimmun Rev 1:298\u2013304","journal-title":"Autoimmun Rev"},{"key":"9_CR14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1191\/0961203303lu447ed","volume":"12","author":"MA Khamashta","year":"2003","unstructured":"Khamashta MA, Shoenfeld Y (2003) Antiphospholipid syndrome: a consensus for treatment? Lupus 12:495","journal-title":"Lupus"},{"key":"9_CR15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1191\/0961203303lu388oa","volume":"12","author":"D Alargon-Segovia","year":"2003","unstructured":"Alargon-Segovia D, Boffa MC, Branch W, Cervera R, Gharavi A, Khamashta MA et al (2003) Prophylaxis of the antiphospholipid syndrome: a consensus report. Lupus 12:499\u2013503","journal-title":"Lupus"},{"key":"9_CR16","first-page":"215","volume":"68","author":"EN Harris","year":"1987","unstructured":"Harris EN, Gharavi AE, Patel SP, Hughes GRV (1987) Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 68:215\u2013222","journal-title":"Clin Exp Immunol"},{"key":"9_CR17","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2249.1999.01007.x","volume":"117","author":"G Lakos","year":"1999","unstructured":"Lakos G, Kiss E, Regeczy N, Tarjan P, Zeher M, Bodolay E et al (1999) Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (b2-GPI) antibodies: importance of IgA isotype. Clin Exp Immunol 117:574\u2013579","journal-title":"Clin Exp Immunol"},{"key":"9_CR18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1055\/s-0038-1648143","volume":"65","author":"T Exner","year":"1991","unstructured":"Exner T, Triplett DA, Taberner D, Machin SJ (1991) Guidelines for the testing and revised criteria for lupus anticoagulant. Thromb Haemost 65:320\u2013322","journal-title":"Thromb Haemost"},{"key":"9_CR19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/08916930400022608","volume":"38","author":"I Marai","year":"2005","unstructured":"Marai I, Trincani A, Balestrieri G, Shoenfeld Y (2005) Anti-cardiolipin and anti-beta2-glycoprotein I antibodies. Autoimmunity 38:33\u201338","journal-title":"Autoimmunity"},{"key":"9_CR20","first-page":"499","volume":"23","author":"E Toubi","year":"2005","unstructured":"Toubi E, Krause I, Freser A, Lev S, Stojanovits L, Rovensky J, Blank M, Shoenfeld Y (2005) Livedo reticularis is a marker for predicting multi-system thrombosis in antiphospholipid syndrome. Clin Exp Rheumatol 23:499\u2013504","journal-title":"Clin Exp Rheumatol"},{"key":"9_CR21","first-page":"55","volume":"5","author":"Y Shoenfeld","year":"2006","unstructured":"Shoenfeld Y, Blank M, Cervera R, Font J, Raschi E, Meroni PL (2006) Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis 5:55\u201363","journal-title":"Ann Rheum Dis"},{"key":"9_CR22","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(00)04239-2","volume":"357","author":"G Ruiz-Irastorza","year":"2001","unstructured":"Ruiz-Irastorza G, Khamashta MA, Castellino G, Hughes GRV (2001) Systemic lupus erythematosus. Lancet 357:1027\u20131032","journal-title":"Lancet"},{"key":"9_CR23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1191\/096120398678919624","volume":"7","author":"NM Shah","year":"1998","unstructured":"Shah NM, Khamashta MA, Atsumi T, Hughes GR (1998) Outcome of patients with anticardiolipin antibodies: a 10\u00a0year follow-up of 52 patients. Lupus 7:3\u20136","journal-title":"Lupus"},{"key":"9_CR24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.7326\/0003-4819-117-4-303","volume":"117","author":"MH Rosove","year":"1992","unstructured":"Rosove MH, Brewer PM (1992) Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 117:303\u2013308","journal-title":"Ann Intern Med"},{"key":"9_CR25","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1191\/0961203303lu389oa","volume":"12","author":"PL Meroni","year":"2003","unstructured":"Meroni PL, Moia M, Derksen RH, Tincani A, McIntyre JA, Arnout JM et al (2003) Venous thromboembolism in the antiphospholipid syndrome management guidelines for secondary prophylaxis. Lupus 12:504\u2013507","journal-title":"Lupus"},{"key":"9_CR26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1191\/0961203303lu390oa","volume":"12","author":"RL Brey","year":"2003","unstructured":"Brey RL, Chapman J, Leine SR, Ruiz-Irastroza G, Derksen RH, Khamashta MA et al (2003) Stroke and the antiphospholipid syndrome: consensus meet Taormina 2002. Lupus 12:508\u2013513","journal-title":"Lupus"},{"key":"9_CR27","first-page":"985","volume":"30","author":"G Sanna","year":"2003","unstructured":"Sanna G, Bertolaccini ML, Cuadrado MJ, Laing H, Khamashta MA, Mathieu A et al (2003) Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 30:985\u2013992","journal-title":"J Rheumatol"},{"key":"9_CR28","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","volume":"46","author":"R Cervera","year":"2002","unstructured":"Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT et al (2002) For the Euro-Phospholipid Project Group. Antiphospholipid syndrome. Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 46:1019\u20131027","journal-title":"Arthritis Rheum"},{"key":"9_CR29","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMe038131","volume":"349","author":"MD Lockshin","year":"2003","unstructured":"Lockshin MD, Erkan D (2003) Treatment of antiphospholipid syndrome. N Engl J Med 349:1177\u20131179","journal-title":"N Engl J Med"},{"key":"9_CR30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1568-9972(02)00147-7","volume":"2","author":"RA Asherson","year":"2003","unstructured":"Asherson RA, Cervera R (2003) The antiphospholipid syndrome: multiple faces beyond the classical presentation. Autoimmun Rev 2:140\u2013151","journal-title":"Autoimmun Rev"},{"key":"9_CR31","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1191\/0961203303lu391oa","volume":"12","author":"M Lockshin","year":"2003","unstructured":"Lockshin M, Tenedios F, Petri M, Mccarty G, Forastiro R, Krillis S et al (2003) Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report. Lupus 12:518\u2013523","journal-title":"Lupus"},{"key":"9_CR32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/sj.thj.6200206","volume":"4","author":"M Galli","year":"2003","unstructured":"Galli M, Barbui T (2003) Antiphospholipid antibodies and thrombosis: strength of association. Hematol J 4:180\u2013186","journal-title":"Hematol J"},{"key":"9_CR33","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1191\/0961203303lu393oa","volume":"12","author":"Tincania","year":"2003","unstructured":"Tincania, Branch W, Levy RA, Piette JC, Carp H, Rai RS et al (2003) Treatment of pregnant patients with antiphospholipid syndrome. Lupus 12:524\u2013529","journal-title":"Lupus"},{"key":"9_CR34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1568-9972(02)00142-8","volume":"2","author":"G Zandman-Goddard","year":"2003","unstructured":"Zandman-Goddard G, Blank M, Sherer Y, Ehrenfeld M, Chapman J, Orbach H, Gilburd B, Krause I, Shoenfeld Y (2003) 10th International Congress on antiphospholipid antibodies\u2014summary. Autoimmun Rev 2:79\u201385","journal-title":"Autoimmun Rev"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-007-0009-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-007-0009-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-007-0009-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:48:38Z","timestamp":1559440118000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-007-0009-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,9]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,9,21]]}},"alternative-id":["9"],"URL":"https:\/\/doi.org\/10.1007\/s12016-007-0009-8","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,9]]}}}